Hannele Ruohola-Baker
University of Washington, Seattle, WA, USA
Department of Biochemistry
Institute for Stem Cell and Regenerative Medicine (ISCRM)
Department of Biology (adjunct)
Department of Genome Sciences (adjunct)
Department of Bioengineering (adjunct)
Department of Oral Health Sciences, School of Dentistry (adjunct)
Program in Neurobiology and Behavior
Center of Human Development and Disability
Hannele Ruohola-Baker is a Professor of Biochemistry and Co-Director of the Institute for Stem Cell and Regenerative Medicine at the University of Washington in Seattle, Washington.
Born in Finland, she received her bachelor’s and master’s degrees from the University of Helsinki, along with a Ph.D. in cell biology from Yale University. Then, she conducted a visiting fellowship at the Ludwig Institute for Cancer Research at the Karolinska Institute in Stockholm and subsequently a postdoctoral fellowship at the University of California, San Francisco.
Ruohola-Baker’s research focuses on stem cells and the molecular requirements for differentiation, with particular interest in the role of microRNA and in the relationship between metabolism and epigenetic changes in different types of stem cells. Her research group has a long-standing interest in using novel, AI-designed proteins to unravel the rules of regeneration. The group’s work has been highlighted over 120 times as publications in prestigious journals.
Born in Finland, she received her bachelor’s and master’s degrees from the University of Helsinki, along with a Ph.D. in cell biology from Yale University. Then, she conducted a visiting fellowship at the Ludwig Institute for Cancer Research at the Karolinska Institute in Stockholm and subsequently a postdoctoral fellowship at the University of California, San Francisco.
Ruohola-Baker’s research focuses on stem cells and the molecular requirements for differentiation, with particular interest in the role of microRNA and in the relationship between metabolism and epigenetic changes in different types of stem cells. Her research group has a long-standing interest in using novel, AI-designed proteins to unravel the rules of regeneration. The group’s work has been highlighted over 120 times as publications in prestigious journals.